Skip to main content
Equibles

Noriyuki Kasahara, M.D., Ph.D.

Board Member

4D Molecular Therapeutics, Inc. (FDMT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Noriyuki Kasahara, M.D., Ph.D.

Noriyuki Kasahara, M.D., Ph.D. is recorded as Board Member at 4D Molecular Therapeutics, Inc. (FDMT). 4D Molecular Therapeutics, Inc. reported in an 8-K filed January 4, 2024 that Noriyuki Kasahara, M.D., Ph.D. resigned as member and the Chair of the Science and Technology Committee of the Board, effective January 1, 2024. 4D Molecular Therapeutics, Inc. reported in an 8-K filed September 27, 2022 that Noriyuki Kasahara, M.D., Ph.D. was appointed Class I director, effective September 23, 2022.

“On January 1, 2024, Dr. Kasahara delivered notice of his resignation from the Board of the Company, including his role as a member and the Chair of the Science and Technology Committee of the Board, effective on January 1, 2024.”
4D Molecular Therapeutics, Inc. Form 8-K, filed January 4, 2024 · Read the filing
“On September 23, 2022, the Board of Directors (the “Board”) of 4D Molecular Therapeutics, Inc. (the “Company”) appointed Noriyuki Kasahara, M.D., Ph.D., to the Board as a Class I director, to serve for a term expiring at the Company’s 2024 annual meeting of stockholders.”
4D Molecular Therapeutics, Inc. Form 8-K, filed September 27, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at 4D Molecular Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.